Parmax Pharma Ltd share price logo

Parmax Pharma Share Price

BSE: 540359

Small Cap

Healthcare Sector

₹39.99

+3.00

(+8.11%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Parmax Pharma Stock Performance

as on January 9, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹33.06
    ₹40
    downward going graph

    17.33%

    Downside

    0.03%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹28
    ₹55.02
    downward going graph

    29.98%

    Downside

    37.58%

    Upside

    downward going graph

Parmax Pharma share price movements today

Previous Close
₹36.99
Open
₹36.99
Volume
6,170.00
Upper Circuit
₹44.38
Lower Circuit
₹29.60
Day's Low - High
₹33.06 - ₹40
52 Week Low - High
₹28 - ₹55.02

Parmax Pharma Historical Returns

1 Month Return
+ 13.93 %
3 Month Return
+ 24.38 %
1 Year Return
-9.1 %
3 Year Return
+ 3.93 %
5 Year Return
+ 50.4 %

Parmax Pharma Fundamentals

as on January 9, 2026 at 4:01 pm IST

Market Cap

₹14.66 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

-0.4

P/B Ratio

-9.45

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

845.45

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Parmax Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Parmax Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Parmax Pharma Ltd image
Parmax Pharma Ltd
NA14.6610.08%0.00-328
Piramal Pharma Ltd image
Piramal Pharma Ltd
BUY22,401.82-2.26%0.69919,151
Venmax Drugs & Pharmaceuticals Ltd image
Venmax Drugs & Pharmaceuticals Ltd
NA21.1760.36%0.00-1NA
Infinium Pharmachem Ltd image
Infinium Pharmachem Ltd
NA349.8440.76%0.697155
Kobo Biotech Ltd image
Kobo Biotech Ltd
NA5.93-12.51%0.00-6NA
See all

Parmax Pharma Share Price Target

Get share price movements and forecasts by analysts on Parmax Pharma.

Source: S&P Global Market Intelligence

Parmax Pharma Stock’s Investor Sentiment and Interest

Search interest for Parmax Pharma Ltd Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Parmax Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
6.38
1.4
4.07
1.33
4.26
7.82
9.28
6.28
4.83
1.94
2.53
Other Income
0.01
0.01
0.01
0.01
0.01
0.01
0.12
0.01
-0.1
0.01
0.01
Total Income
6.4
1.41
4.08
1.34
4.27
7.82
9.39
6.3
4.73
1.95
2.54
Expenses
5.55
2.05
4.83
2.48
5.06
7.3
9.08
6.18
6.46
2.19
4.12
Operating Profit
0.83
-0.65
-0.76
-1.15
-0.8
0.52
0.2
0.1
-1.63
-0.25
-1.59
Operating Profit Margin %
13.01%
-46.43%
-18.67%
-86.47%
-18.78%
6.65%
2.16%
1.59%
-33.75%
-12.89%
-62.85%
Profit Before Interest, Tax and Depreciation
0.85
-0.64
-0.75
-1.14
-0.79
0.52
0.32
0.12
-1.74
-0.24
-1.58
Interest
0.05
0.12
0.18
0.16
0.16
0.11
0.13
0.11
0.24
0.28
0.24
Depreciation
0.47
0.42
0.43
0.45
0.41
0.4
0.4
0.41
-0.18
0.24
0.26
Profit Before Tax
0.33
-1.18
-1.36
-1.75
-1.36
0.01
-0.21
-0.4
-1.8
-0.76
-2.08
Tax Paid
0.16
-
-
-
0.09
-
-
-
-0.3
-
-
Profit After Tax
0.17
-1.18
-1.37
-1.75
-1.45
0.01
-0.22
-0.39
-1.49
-0.76
-2.08
Total Net profit including share of profit / Loss from associate company
0.17
-1.18
-1.37
-1.75
-1.45
0.01
-0.22
-0.39
-1.49
-0.76
-2.08
EPS
0.46
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56
Actual EPS
0.46
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56
Adjusted EPS
0.46
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56
Diluted EPS
0.46
-3.15
-3.66
-4.68
-3.88
0.03
-0.58
-1.05
-4
-2.04
-5.56

Parmax Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
-
11.9
12.01
20.93
26.2
18.25
15.42
11.05
28.2
Other Income
0.06
0.05
0.05
0.1
0.09
0.06
0.04
0.05
0.04
Total Income
0.06
11.95
12.06
21.03
26.29
18.31
15.46
11.1
28.24
Expenses
0.05
10.82
10.9
19.17
22.79
15.69
13.17
14.42
29.02
Operating Profit
-0.05
1.08
1.11
1.76
3.41
2.56
2.25
-3.37
-0.82
Operating Profit Margin %
0%
9.08%
9.24%
8.41%
13.02%
14.03%
14.59%
-30.5%
-2.91%
Profit Before Interest, Tax and Depreciation
0.01
1.13
1.16
1.87
3.5
2.62
2.29
-3.32
-0.78
Interest
-
0.03
0.03
0.13
0.35
0.39
0.37
0.62
0.59
Depreciation
-
1.09
1.03
1.01
1.94
1.93
1.88
1.71
1.03
Profit Before Tax
0.01
0.01
0.1
0.73
1.21
0.3
0.04
-5.65
-2.4
Tax Paid
0.01
0.01
0.02
0.3
0.46
0.17
0.16
0.09
-0.3
Profit After Tax
-0.01
-
0.08
0.43
0.75
0.14
-0.1
-5.75
-2.09
Total Net profit including share of profit / Loss from associate company
-0.01
-
0.08
0.43
0.75
0.14
-0.1
-5.75
-2.09
EPS
-0.02
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6
Actual EPS
-0.02
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6
Adjusted EPS
-0.02
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6
Diluted EPS
-0.02
-
0.21
1.15
2.02
0.38
-0.28
-15.37
-5.6

Parmax Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-
-0.5
3.88
0.92
2.82
3.53
0.75
0.33
-0.2
-0.96
Cash Flow from Investing Activities
-
-0.19
-4.23
-3.41
-2.4
-3.15
-1.53
-0.94
-1.59
-0.7
Cash Flow from Financing Activities
0.09
0.56
1.14
3.1
-0.23
0.4
-0.91
-0.04
1.43
1.4
Net Cash Flow
0.09
-0.14
0.79
0.61
0.2
0.78
-1.69
-0.65
-0.36
-0.26

Parmax Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
30.8%
30.8%
30.8%
30.8%
30.83%
30.8%
30.8%
30.8%
30.8%
30.8%
30.8%
Public
69.2%
69.2%
69.2%
69.2%
69.17%
69.2%
69.2%
69.2%
69.2%
69.2%
69.2%
Total Outstanding Shares
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
37,41,300
Total Shareholders
1,997
1,978
1,973
2,002
2,099
2,185
2,246
2,334
2,356
2,377
2,399

Parmax Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Parmax Pharma.

  • Parmax Pharma Ltd Earnings Results

    Parmax Pharma Ltd’s net profit fell -845.45% since last year same period to ₹-2.08Cr in the Q2 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated -173.68% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Parmax Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Parmax Pharma stock has moved up by 13.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 30.80% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.2% return, outperforming this stock by 149.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 21.0% return, outperforming this stock by 30.1%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 69.20% of holdings in Sep 2025 quarter

About Parmax Pharma Ltd

Parmax Pharma PPL is a public limited company which was incorporated in November 1994 and promoted by Jayantilal S Dhol Purushottam J Bhalodi and Prabhudas D Hansalpara. It has set up a plant in Hadamtala Gujarat and has an installed capacity of 96 tonnes per annum for the production of bulk drugs such as amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid. Its Antibiotic project has been completely implemented since 31st May 1997 and its non Antibiotic products project is currently in its final stages of implementation.

Revenue: ₹2.53Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-2.08Cr as on September 2025 (Q2 FY26)
OrganisationParmax Pharma Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Parmax Pharma share price today?

Parmax Pharma share price today stands at ₹39.99 as on at the close of the market. Parmax Pharma share today touched a day high of ₹40 and a low of ₹33.06.

What is the 52 week high and 52 week low range for Parmax Pharma share?

Parmax Pharma touched a 52 week high of ₹55.02 and a 52 week low of ₹28. Parmax Pharma share price today i.e. is closed at ₹39.99, which is -27.32% down from its 52 week high and 42.82% up from its 52 week low.

What is Parmax Pharma's market capitalisation today?

Parmax Pharma market capitalisation is ₹14.66 Cr as on .

How to buy Parmax Pharma shares?

To buy Parmax Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 540359 or Parmax Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Parmax Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Parmax Pharma trading volume today?

Parmax Pharma trading volume is 6,170.00 as on . This means that 6,170.00 shares of Parmax Pharma were bought and sold on the stock market during today's trading session.